REAL-WORLD HEALTH CARE UTILIZATION COSTS IN HEMOPHILIA B PATIENTS USING STANDARD AND EXTENDED HALF-LIFE RECOMBINANT FACTOR IX PRODUCTS

Chhabra A.; Alvir J.; Tortella B. J.; Fogarty P. F.; Spurden D.; McDonald M.; Pleil A.

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >REAL-WORLD HEALTH CARE UTILIZATION COSTS IN HEMOPHILIA B PATIENTS USING STANDARD AND EXTENDED HALF-LIFE RECOMBINANT FACTOR IX PRODUCTS

【24h】

REAL-WORLD HEALTH CARE UTILIZATION COSTS IN HEMOPHILIA B PATIENTS USING STANDARD AND EXTENDED HALF-LIFE RECOMBINANT FACTOR IX PRODUCTS

机译：使用标准和延长半衰期重组因子IX产品的血友病B患者现实世界卫生利用成本

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2017年第5期|共1页
作者
Chhabra A.; Alvir J.; Tortella B. J.; Fogarty P. F.; Spurden D.; McDonald M.; Pleil A.;
展开▼
作者单位

Pfizer Inc New York NY USA;

Pfizer Inc New York NY USA;

Pfizer Inc Collegeville PA USA;

Pfizer Inc Collegeville PA USA;

Pfizer Ltd Tadworth Surrey England;

Pfizer Ltd Tadworth Surrey England;

Pfizer Inc San Diego CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. REAL-WORLD HEALTH CARE UTILIZATION COSTS IN HEMOPHILIA B PATIENTS USING STANDARD AND EXTENDED HALF-LIFE RECOMBINANT FACTOR IX PRODUCTS [J] . Chhabra A., Alvir J., Tortella B. J., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：使用标准和延长半衰期重组因子IX产品的血友病B患者现实世界卫生利用成本
2. ANALYSIS OF REAL-WORLD CLAIMS DATA ASSOCIATED WITH A STANDARD AND AN EXTENDED HALF-LIFE RECOMBINANT FACTOR IX PRODUCT IN US PEDIATRIC PATIENTS WITH HEMOPHILIA B [J] . Fogarty Patrick, Spurden Dean, Chhabra Amit, Pediatric blood & cancer . 2018,第Suppla1期

机译：与血友病患者B的标准和延长半衰期重组因子IX产品的现实世界声明数据分析
3. REAL-WORLD SPECIALTY PHARMACY DISPENSATION AND EXPENDITURES ASSOCIATED WITH STANDARD AND EXTENDED HALF-LIFE RECOMBINANT FACTOR IX PRODUCTS AMONG HEMOPHILIA B PATIENTS RECEIVING ON-DEMAND REGIMENS [J] . Fogarty Patrick F., Alvir Jose, Chhabra Amit, American Journal of Hematology . 2018,第9期

机译：与按需方案接受按需方案的血友病患者中的标准和延长半衰期重组因子IX产品相关的现实世界专业药房分配和支出
4. Factor VllhC Measurement - Comparison between chromogenic and coagulometric Methods in Hemophilia A-Patients with the B-Domain depleted recombinant F VIII-Preparation ReFacto [C] . A. Siegemund, T. Siegemund, U. Scholz, Hemophilie-Symposion . 2003

机译：因子VLLHC测量 - 血友病患者血友病患者的色情和凝血法的比较鉴定重组F VIII制剂refacto
5. Investigating Strategies To Improve Health Care Labor Market, Health Outcomes, Health Care Quality, And To Reduce Emergency Department Utilization And Costs: A Study Of The Effectiveness Of Family Friendly Policies, Patient-Centered Communication, And Enhanced Access To Care [D] . Tayou, Juliette Guemmegne. 2017

机译：调查策略，以改善卫生保健劳动力市场，卫生成果，卫生保健质量并减少急诊部门的使用和成本：家庭友好政策，以患者为中心的沟通和增强的就医机会的有效性研究
6. Comparison of extended to standard half-life recombinant factor VIII therapy in patients with hemophilia A on prophylactic therapy [O] . Michael McCall, Pamela Koerner, Rick Miller, 2019

机译：预防性治疗血友病A患者延长至标准半衰期重组因子VIII治疗的比较
7. Real-World Health Care Expenditure In Hemophilia A Patients Using Standard And Extended Half-Life Recombinant Factor VIII Products [O] . D Spurden, PF Fogarty, A Chhabra, 2017

机译：血友病的现实世界医疗支出A患者使用标准和延长半衰期重组因子VIII产品

REAL-WORLD HEALTH CARE UTILIZATION COSTS IN HEMOPHILIA B PATIENTS USING STANDARD AND EXTENDED HALF-LIFE RECOMBINANT FACTOR IX PRODUCTS

著录项

相似文献

相关主题

期刊订阅